Alexander Fleming and Roger Mason (eds), Scotland and the Flemish People

2020 ◽  
Vol 40 (1) ◽  
pp. 72-73
Author(s):  
Jane E. A. Dawson
Keyword(s):  
2007 ◽  
Vol 15 (4) ◽  
pp. 234-234 ◽  
Author(s):  
Neil McIntyre
Keyword(s):  

1989 ◽  
Vol 12 (2) ◽  
pp. 110-112 ◽  
Author(s):  
H. Berger
Keyword(s):  

1986 ◽  
Vol 1 (3) ◽  
pp. 205-209 ◽  
Author(s):  
Judith Deas ◽  
Peter Billings ◽  
Sean Brennan ◽  
Ian Silver ◽  
David Leaper

We have allowed the liberal use of antiseptics for wound care to become an established practice with little consideration of any toxicity on exposed healing tissues. The care of open wounds and chronic ulcers is largely delegated to nursing staff with little help or advice from their medical colleagues. Alexander Fleming felt that antiseptics would only be of benefit in septic wounds if they stimulated or conserved natural defence mechanisms! He also regarded the assessment of tissue toxicity as being more important than any antimicrobial effect but there has been little research into this field.


Author(s):  
Maria José Saavedraa ◽  
João Carlos Sousa

Resumo A elevada mortalidade pelas doenças infecciosas, sobretudo epidémicas, mobilizou os cientistas na pesquisa de compostos naturais e produtos de síntese química dotados de propriedades antimicrobianas. Fazendo um pouco de história, referimos Paul Ehrlich, que utilizou o primeiro agente quimioterapêutico -Salvarsan, mais tarde Gerhard Domagk, que utilizou um pro-fármaco percursor de uma sulfamida. Em 1928, Alexander Fleming, descobriu de forma “casual” a penicilina, o primeiro antibiótico. Posteriormente em 1941 Howard Florey e Ernest Chain isolam e purificam a penicilina o que permitiu a sua utilização em larga escala -Era dos Antibióticos. A utilização dos antibióticos (AB) no tratamento das doenças infecciosas constituiu um dos maiores avanços da Medicina no séc. XX. No entanto a sua utilização em larga escala promoveu o aumento da incidência de estirpes multiresistentes aos AB, sobretudo em ambiente hospitalar. Adicionalmente verifica-se uma ocorrência cada vez mais elevada de estirpes resistentes na comunidade–humanos, animais e ambiente. O conhecimento dos mecanismos de ação e da ineficácia dos diferentes grupos farmacológicos de antibióticos é vital para o desenvolvimento de futuros microbianos, estando a ser estudados microrganismos do solo com a finalidade de encontrara novos fármacos. De realçar que a OMS preconiza que caminhamos rumo a uma "era pós-antibiótico”. Se não houver um plano de ação global para o "uso racional de antibióticos" a OMS prevê que em 2050 a resistência aos antibióticos, poderá matar mais de 10 milhões de pessoas.Palavras-chave: antibioterapia; resistência; antibióticos Abstract The current research on infectious diseases, especially with epidemic potential, has mobilized the scientific community to research on the natural substance and chemical probing products with antimicrobial properties. In a brief history of antibiotics, we refer to Paul Ehrlich, who used the first chemotherapeutic agent - Salvarsan, later Gerhard Domagk, who used a sulfamide precursor prodrug. In 1928 Alexander Fleming "casually" discovered penicillin, the first antibiotic. Later in 1941 Howard Florey and Ernest Chain isolate and purify penicillin that can be used on a large scale - Antibiotics Era. The use of antibiotics (AB) in the treatment of infectious diseases is one of the greatest advances of medicine in the 19th century. However, its large-scale use has increased the incidence of multidrug-resistant processes in AB, especially in a hospital setting. Besides, there is an increasing occurrence of resistant strains in different communities - humans, animals and in the environment. Understand the mechanisms of action and the ineffectiveness of the diverse pharmacological groups of antibiotics is crucial to provide further new antibiotic therapies in the near future. Recent studies have highlighted the soil-derived microorganisms as a novel approach to identify new drug substances. In this context, it is noteworthy that the World Health Organization (WHO) considers that we are moving towards a “post-antibiotic era”. If there is no global action plan for “rational use of antibiotics” WHO predicts that in 2050 the global impacts of antibiotic resistance on human heath will be catastrophic, killing more than 10 million people worldwide. Keywords: antibiotic therapy; resistence; antibiotics


2011 ◽  
pp. S1-S13 ◽  
Author(s):  
P. R. ANDJUS ◽  
S. S. STOJILKOVIC ◽  
G. CVIJIC

The founder of physiology studies in the Balkans and the pioneer of research on hypothermia, Ivan Djaja (Jean Giaja) was born 1884 in L’Havre. Giaja gained his PhD at the Sorbonne in 1909. In 1910 he established the first Chair of Physiology in the Balkans and organized the first Serbian Institute for Physiology at the School of Philosophy of the University of Belgrade. He led this Institute for more than 40 subsequent years. His most notable papers were in the field of thermoregulation and bioenergetics. Djaja became member of the Serbian and Croatian academies of science and doctor honoris causa of Sorbonne. In 1952 for the seminal work on the behavior of deep cooled warm blooded animals he became associate member of the National Medical Academy in Paris. In 1955 the French Academy of Sciences elected him as associate member in place of deceased Sir Alexander Fleming. Djaja died in 1957 during a congress held in his honor. He left more than 200 scientific and other papers and the golden DaVincian credo “Nulla dies sine experimento”. His legacy was continued by several generations of researchers, the most prominent among them being Stefan Gelineo, Radoslav Andjus and Vojislav Petrović.


2002 ◽  
Vol 177 (1) ◽  
pp. 52-53
Author(s):  
Ivo D Vellar ◽  
Thomas B Hugh ◽  
Peter D Goldsworthy ◽  
Alexander C McFarlane
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document